Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Blackstone and TPG
Acquired Company
Hologic
New YorkMarlboroughFinancial ServicesReal EstateFinanceReal Estate InvestmentVenture CapitalAngel InvestmentBiotechnologyHealth CareMedicalMedical DeviceDescription
Hologic, Inc. became a private company on April 7, 2026, after being acquired by Blackstone and TPG in a transaction valued at $18.3 billion. Shareholders received $76.00 in cash plus a contingent value right worth up to $3.00 per share. This acquisition ends Hologic's public trading on Nasdaq and marks its transition to private ownership.
Fundz sees it the moment Blackstone and TPG makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Hologic?
Hologic was acquired by Blackstone and TPG, based in New York. The deal was reported on September 29, 2026. Blackstone is a global investment firm that specializes in private equity, credit, and hedge fund investment strategies. Blackstone and TPG is privately held and operates in Financial Services.
When did Blackstone and TPG acquire Hologic?
Blackstone and TPG's acquisition of Hologic was reported on September 29, 2026. Hologic, Inc. became a private company on April 7, 2026, after being acquired by Blackstone and TPG in a transaction valued at $18.3 billion. Shareholders received $76.00 in cash plus a contingent value right worth up to $3.00 per share. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Hologic do?
Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. It is privately held, operating in Biotechnology, and is based in Marlborough.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.